nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A convolutional neural network–based system for fully automatic segmentation of whole-body [68Ga]Ga-PSMA PET images in prostate cancer
|
Jafari, Esmail |
|
|
51 |
5 |
p. 1476-1487 |
artikel |
2 |
Adhesion molecule–targeted magnetic particle imaging nanoprobe for visualization of inflammation in acute lung injury
|
Gao, Pengli |
|
|
51 |
5 |
p. 1233-1245 |
artikel |
3 |
Advances in targeted alpha therapy of cancer
|
Sathekge, Mike |
|
|
51 |
5 |
p. 1205-1206 |
artikel |
4 |
After one year of ChatGPT’s launch: reflections on artificial intelligence in scientific writing
|
Feng, Yuan |
|
|
51 |
5 |
p. 1203-1204 |
artikel |
5 |
Alpha emitter isotopes and PSMA ligands: the near future therapeutic prospective for castration-resistant prostate cancer
|
Volpe, Fabio |
|
|
51 |
5 |
p. 1207-1209 |
artikel |
6 |
Automated identification of uncertain cases in deep learning-based classification of dopamine transporter SPECT to improve clinical utility and acceptance
|
Budenkotte, Thomas |
|
|
51 |
5 |
p. 1333-1344 |
artikel |
7 |
A. Zaheer, S.P. Raman, M.L. Rosado-de-Christenson, S. Martínez-Jiménez, S.H. Garrana, G. Fananapazir, D. Rogers, B.R. Foster: Imaging Anatomy: Chest, Abdomen, Pelvis, 3rd Edition
|
Mansi, Luigi |
|
|
51 |
5 |
p. 1201-1202 |
artikel |
8 |
Beyond stillness: the importance of tackling patient’s motion for reliable parametric imaging
|
Artesani, Alessia |
|
|
51 |
5 |
p. 1210-1212 |
artikel |
9 |
Comparative assessment of radiation therapy–induced vasculitis using [18F]FDG-PET/CT in patients with non-small cell lung cancer treated with proton versus photon radiotherapy
|
Evanson, D. |
|
|
51 |
5 |
p. 1444-1450 |
artikel |
10 |
Correction to: Theranostic role of 89Zr‑ and 177Lu‑labeled aflibercept in breast cancer
|
Yang, Qi |
|
|
51 |
5 |
p. 1495 |
artikel |
11 |
CXCR4-directed PET/CT with [68 Ga]Ga-pentixafor in solid tumors—a comprehensive analysis of imaging findings and comparison with histopathology
|
Dreher, Niklas |
|
|
51 |
5 |
p. 1383-1394 |
artikel |
12 |
Detection of metabolic adaptation in a triple-negative breast cancer animal model with [18F]choline-PET imaging as a surrogate for drug resistance
|
Kohan, Andres A. |
|
|
51 |
5 |
p. 1261-1267 |
artikel |
13 |
Development and validation of clinical-radiomics analysis for preoperative prediction of IDH mutation status and WHO grade in diffuse gliomas: a consecutive l-[methyl-11C] methionine cohort study with two PET scanners
|
Zhou, Weiyan |
|
|
51 |
5 |
p. 1423-1435 |
artikel |
14 |
Dynamic total-body PET/CT imaging with reduced acquisition time shows acceptable performance in quantification of [18F]FDG tumor kinetic metrics
|
Liu, Guobing |
|
|
51 |
5 |
p. 1371-1382 |
artikel |
15 |
EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials
|
Stokke, Caroline |
|
|
51 |
5 |
p. 1268-1286 |
artikel |
16 |
Effects of medication on dopamine transporter imaging using [123I]I-FP-CIT SPECT in routine practice
|
Piatkova, Yuliya |
|
|
51 |
5 |
p. 1323-1332 |
artikel |
17 |
Expanding the clinical indications of [18F]fluorocholine PET/CT in primary hyperparathyroidism: the evidence cannot be evaded
|
Treglia, Giorgio |
|
|
51 |
5 |
p. 1345-1348 |
artikel |
18 |
FDG-PET/CT for investigation of pyrexia of unknown origin: a cost of illness analysis
|
Liu, Bonnia |
|
|
51 |
5 |
p. 1287-1296 |
artikel |
19 |
[18F]FDG PET/CT for therapeutic assessment of Abatacept in early-onset polymyalgia rheumatica
|
Allard, Bastien |
|
|
51 |
5 |
p. 1297-1309 |
artikel |
20 |
First-in-human SPECT/CT imaging of [212Pb]Pb-VMT-α-NET in a patient with metastatic neuroendocrine tumor
|
Michler, Enrico |
|
|
51 |
5 |
p. 1490-1492 |
artikel |
21 |
High-temporal resolution functional PET/MRI reveals coupling between human metabolic and hemodynamic brain response
|
Hahn, Andreas |
|
|
51 |
5 |
p. 1310-1322 |
artikel |
22 |
Impact of patient motion on parametric PET imaging
|
Artesani, Alessia |
|
|
51 |
5 |
p. 1493-1494 |
artikel |
23 |
Incorporating the [68Ga]Ga-PSMA PET/CT PRIMARY score into the selection criteria for prostate cancer patients eligible for active surveillance
|
Kabasakal, Levent |
|
|
51 |
5 |
p. 1464-1466 |
artikel |
24 |
Intense PSMA expression of the uvula detected by [68 Ga]Ga-PSMA-PET/CT
|
Glantschnig, Lisa |
|
|
51 |
5 |
p. 1488-1489 |
artikel |
25 |
Letter to the Editor: FDG Liver Biodistribution
|
Bailey, Dale L. |
|
|
51 |
5 |
p. 1213-1214 |
artikel |
26 |
[177Lu]Lu-labeled anti-claudin-18.2 antibody demonstrated radioimmunotherapy potential in gastric cancer mouse xenograft models
|
Zeng, Ziqing |
|
|
51 |
5 |
p. 1221-1232 |
artikel |
27 |
Molecular imaging of IDH-mutant gliomas in the new era of IDH inhibitors: preparing for future challenges
|
Ninatti, Gaia |
|
|
51 |
5 |
p. 1421-1422 |
artikel |
28 |
Multicenter development of a PET-based risk assessment tool for product-specific outcome prediction in large B-cell lymphoma patients undergoing CAR T-cell therapy
|
Voltin, Conrad-Amadeus |
|
|
51 |
5 |
p. 1361-1370 |
artikel |
29 |
Performance of [18F]fluorocholine PET/CT in MEN1-related primary hyperparathyroidism before initial surgery or for persistent/recurrent disease
|
Boucher, Aymeric |
|
|
51 |
5 |
p. 1349-1360 |
artikel |
30 |
Pre-clinical evaluation of biomarkers for the early detection of nephrotoxicity following alpha-particle radioligand therapy
|
Li, Mengshi |
|
|
51 |
5 |
p. 1395-1408 |
artikel |
31 |
Prediction of clinically significant prostate cancer by [68 Ga]Ga-PSMA-11 PET/CT: a potential tool for selecting patients for active surveillance
|
Akcay, Kaan |
|
|
51 |
5 |
p. 1467-1475 |
artikel |
32 |
Prediction of therapy response of breast cancer patients with machine learning based on clinical data and imaging data derived from breast [18F]FDG-PET/MRI
|
Jannusch, Kai |
|
|
51 |
5 |
p. 1451-1461 |
artikel |
33 |
The clinical acceptability of short versus long duration acquisitions for head and neck cancer using long-axial field-of-view PET/CT: a retrospective evaluation
|
Mei, Riccardo |
|
|
51 |
5 |
p. 1436-1443 |
artikel |
34 |
The EANM Focus 5 consensus on ‘molecular imaging and theranostics in prostate cancer’: the future begins today
|
Oprea-Lager, Daniela-Elena |
|
|
51 |
5 |
p. 1462-1463 |
artikel |
35 |
Theranostic role of 89Zr- and 177Lu-labeled aflibercept in breast cancer
|
Yang, Qi |
|
|
51 |
5 |
p. 1246-1260 |
artikel |
36 |
Therapeutic efficacy of an alpha-particle emitter labeled anti-GD2 humanized antibody against osteosarcoma—a proof of concept study
|
Liatsou, Ioanna |
|
|
51 |
5 |
p. 1409-1420 |
artikel |
37 |
Ultra-fast whole-body bone tomoscintigraphies achieved with a high-sensitivity 360° CZT camera and a dedicated deep-learning noise reduction algorithm
|
Bahloul, Achraf |
|
|
51 |
5 |
p. 1215-1220 |
artikel |